We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+14.29%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.45B
AUM Growth
+$519M
Cap. Flow
-$25.5M
Cap. Flow %
-1.04%
Top 10 Hldgs %
32.76%
Holding
158
New
53
Increased
22
Reduced
25
Closed
33

Top Buys

Rank Stock Value
1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$90.2M
2
LH icon
Labcorp
LH
+$65.9M
3
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$53.4M
4
ABBV icon
AbbVie
ABBV
+$51.8M
5
ITMN
INTERMUNE INC
ITMN
+$35.3M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$43.2M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$41.1M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$37.6M
4
GMED icon
Globus Medical
GMED
+$34.2M
5
QCOR
QUESTCOR PHARMA INC
QCOR
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.78%
2 Technology 1.21%
3 Financials 0.56%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
26
DELISTED
Allergan Inc
AGN
$26.8M 1.09%
215,636
+63,636
+42% +$7.75M
GEVA
27
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$26.4M 1.08%
+317,678
New +$29.4M
DGX icon
28
Quest Diagnostics
DGX
$23.1B
$25.5M 1.04%
+440,303
New +$23.6M
DVA icon
29
DaVita
DVA
$15.2B
$24M 0.98%
348,011
-136,989
-28% -$9.1M
KERX
30
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$23.9M 0.98%
1,403,105
-80,155
-5% -$1.21M
XNPT
31
DELISTED
XENOPORT, INC.
XNPT
$22.7M 0.93%
4,384,797
+665,757
+18% +$4.02M
ALNY icon
32
Alnylam Pharmaceuticals
ALNY
$36.5B
$20.3M 0.83%
+302,000
New +$23.4M
PTLA
33
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$19.9M 0.81%
769,848
-55,827
-7% -$1.49M
HZNP
34
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$19.8M 0.81%
1,310,930
-3,327,958
-72% -$37.6M
RNA
35
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$18.1M 0.74%
3,211,372
+91,991
+3% +$570K
OFIX icon
36
Orthofix Medical
OFIX
$469M
$17.8M 0.73%
+591,431
New +$13.6M
ZGNX
37
DELISTED
Zogenix, Inc.
ZGNX
$17.6M 0.72%
771,851
+450,601
+140% +$14.7M
MOH icon
38
Molina Healthcare
MOH
$12B
$17M 0.69%
451,391
-193,580
-30% -$7.13M
TPST icon
39
Tempest Therapeutics
TPST
$15.1M
$15M 0.61%
572
+365
+176% +$10.3M
PETX
40
DELISTED
Aratana Therapeutics, Inc.
PETX
$14.6M 0.6%
+788,904
New +$15.8M
ZTS icon
41
CALL
Zoetis
ZTS
$32B
$14.5M 0.59%
+500,000
New +$15.3M
EHTH icon
42
eHealth
EHTH
$45.1M
$13.8M 0.56%
+271,000
New +$14.1M
LITS
43
Lite Strategy Inc
LITS
$35M
$13M 0.53%
58,229
-4,497
-7% -$811K
AGN
44
CALL
DELISTED
Allergan Inc
AGN
$12.4M 0.51%
+100,000
New +$12.2M
GNCA
45
DELISTED
Genocea Biosciences, Inc.
GNCA
$12M 0.49%
+82,498
New +$10.1M
AERI
46
DELISTED
Aerie Pharmaceuticals
AERI
$12M 0.49%
565,180
+265,180
+88% +$5.36M
ANIP icon
47
ANI Pharmaceuticals
ANIP
$1.78B
$11.6M 0.48%
+371,572
New +$9.86M
FMI
48
DELISTED
Foundation Medicine, Inc.
FMI
$11.1M 0.45%
342,921
-3,097
-0.9% -$101K
IMMU
49
DELISTED
Immunomedics Inc
IMMU
$11.1M 0.45%
+2,628,972
New +$13M
AMAG
50
DELISTED
AMAG Pharmaceuticals
AMAG
$10.4M 0.42%
+534,930
New +$11.4M
1
2
3 4 5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2014 Portfolio in Review

As of Q1 2014, Deerfield Management held 158 positions worth $2.45B, up 27% from $1.93B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Deerfield Management's Q1 2014 filing shows 53 new, 22 increased, 25 reduced and 33 closed positions. Its largest new stake was Dicerna Pharmaceuticals, Inc.: 2,428,569 shares worth $68.6M. The largest sale was Humana, an estimated $43.2M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Technology and Financials.

  • Deerfield Management's largest Q1 2014 buy was Dicerna Pharmaceuticals, Inc.: 2,428,569 shares worth $68.6M.
  • Deerfield Management added most to Insmed in Q1 2014, an estimated $18.3M increase.
  • Deerfield Management's biggest Q1 2014 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $41.1M.
  • Deerfield Management fully exited Humana in Q1 2014, selling an estimated $43.2M.
  • Deerfield Management's ten largest holdings make up 33% of its $2.45B portfolio in Q1 2014.
  • Deerfield Management opened 53 new positions and closed 33 in Q1 2014.
  • Deerfield Management's portfolio value rose 27% quarter-over-quarter to $2.45B.

Based on Deerfield Management's 13F filing for Q1 2014, filed 15 May 2014.